Related Experiment Videos
Monitoring of clinical trials: issues and recommendations
1Department of Biostatistics, University of Washington, Seattle 98195.
Abstract:
Interim analyses of randomized trials enable investigators to make more efficient use of limited research resources and to satisfy ethical requirements that a regimen be discontinued as soon as it has been established to have an inferior efficacy/toxicity profile. Unfortunately, the integrity and credibility of these trials can be compromised if inappropriate procedures are used in monitoring interim data. In this paper we discuss how group sequential designs provide useful guidelines that enable one to satisfy the valid objectives of interim monitoring while avoiding undesirable consequences, and we consider how flexible one can be in the way such designs are implemented. We also provide motivation for the role of data-monitoring committees in preserving study integrity and credibility in either government- or industry-sponsored trials. In our view, these committees should have multidisciplinary representation and membership limited to individuals free of apparent significant conflict of interest, and ideally should be the only individuals to whom the data analysis center provides interim results on relative efficacy of treatment regimens. Finally, we discuss some important practical issues such as estimation following group sequential testing, analysis of secondary outcomes after using a group sequential design applied to a primary outcome, early stopping of negative trials, and the role of administrative analyses.
Insights
Group sequential designs offer guidelines for interim analyses in randomized trials, ensuring ethical standards and efficient resource use while maintaining study integrity. These methods help avoid compromising trial credibility through inappropriate data monitoring.
Area of Science:
- Biostatistics
- Clinical Trials Methodology
- Medical Research Ethics
Background:
- Interim analyses in randomized trials are crucial for efficient resource allocation and ethical considerations.
- Inappropriate interim data monitoring can compromise trial integrity and credibility.
Purpose of the Study:
- To discuss group sequential designs for effective interim monitoring in clinical trials.
- To highlight the importance of data-monitoring committees in preserving study integrity.
- To address practical issues in implementing group sequential designs.
Main Methods:
- Group sequential designs provide a framework for interim data analysis.
- Multidisciplinary data-monitoring committees with no conflicts of interest are recommended.
- Discussion of flexibility in implementing group sequential designs.
Main Results:
- Group sequential designs offer guidelines to balance interim monitoring objectives with trial integrity.
- Data-monitoring committees play a vital role in ensuring credibility for sponsored trials.
- Practical considerations include estimation, secondary outcomes, and early stopping.
Conclusions:
- Group sequential designs are essential for robust interim analyses in randomized trials.
- Independent data-monitoring committees are critical for maintaining study credibility.
- Careful consideration of practical issues ensures the effective application of these designs.